According to the Kaplan-Meier Plotter survival analysis, a higher level expression of CYP1A1 is associated with poor prognosis in gastric cancer patients, with a hazard ration of 1.86 and median survival period of 20.4 months as opposed to 56.9 months in low expression cohort (Figure 6C). The gene discussed is CYP1A1; the disease is gastric cancer.